Nurix Therapeutics, Inc. (NRIX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $14.00M | +51.0% |
| 2024 | $9.27M | +10.4% |
| 2023 | $8.40M | -31.4% |
| 2022 | $12.24M | +116.3% |
| 2021 | $5.66M | +24.3% |
| 2020 | $4.55M | +175.8% |
| 2019 | $1.65M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $14.00M | +51.0% |
| 2024 | $9.27M | +10.4% |
| 2023 | $8.40M | -31.4% |
| 2022 | $12.24M | +116.3% |
| 2021 | $5.66M | +24.3% |
| 2020 | $4.55M | +175.8% |
| 2019 | $1.65M | — |